Compare AngloGold Ashanti Limited (AU) vs ResMed Inc. (RMD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AngloGold Ashanti Limited vs ResMed Inc. — how do they compare? AngloGold Ashanti Limited trades at $101.15 (market cap $49.28B), while ResMed Inc. trades at $220 (market cap $32.61B). The key difference: AngloGold Ashanti Limited is the larger of the two by market cap, and AngloGold Ashanti Limited pays the higher dividend (4.64%). Which is the better fit depends on your goals.
| AU | RMD | |
|---|---|---|
Market Cap | $49.28B | $32.61B |
Sector | Basic Materials | Health |
52-Week High | $128.26 | $293.73 |
52-Week Low | $52.15 | $182.82 |
Enterprise Value | $48.29B | $31.97B |
Dividend Yield | 4.64% | 1.17% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About AngloGold Ashanti Limited
Anglogold Ashanti Ltd is one of the largest gold miners. The company also produces silver and sulphuric acid as by-products. Its operating divisions are Africa, Australia, and the Americas. The firm generates a majority of its revenue from Africa which includes Ghana, Guinea, Mali, the Democratic Republic of the Congo, and Tanzania.
Read more on AU →About ResMed Inc.
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
Read more on RMD →
